Baxter International Inc. (NYSE:BAX) marked $55.37 per share on Thursday, down from a previous closing price of $55.47. While Baxter International Inc. has underperformed by -0.18%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, BAX fell by -31.68%, with highs and lows ranging from $89.70 to $54.45, whereas the simple moving average fell by -24.89% in the last 200 days.
Top 5 Cheap Stocks to Own Right Now
While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.
Sign up here to get your free report now.
On June 24, 2022, Wells Fargo Downgraded Baxter International Inc. (NYSE: BAX) to Equal Weight. A report published by Goldman on April 04, 2022, Downgraded its rating to ‘Sell’ for BAX. BofA Securities also rated BAX shares as ‘Buy’, setting a target price of $100 on the company’s shares in an initiating report dated March 02, 2022. Wells Fargo Reiterated the rating as Overweight on February 18, 2022, but set its price target from $95 to $93. UBS resumed its ‘Neutral’ rating for BAX, as published in its report on February 18, 2022. Stifel’s report from February 18, 2022 suggests a price prediction of $91 for BAX shares, giving the stock a ‘Buy’ rating. Raymond James also rated the stock as ‘Outperform’.
Analysis of Baxter International Inc. (BAX)
BAX currently pays a dividend of $1.16 per share, which means investors will get a return regardless of the company’s performance over the next few months. Further, the quarter-over-quarter increase in sales is 20.90%, showing a positive trend in the upcoming months.
In order to gain a clear picture of Baxter International Inc.’s future performance, a variety of well-rounded analysis and research techniques can be applied, with equity being the most critical. The goal here is to ensure that your current return on equity of 11.30% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 1.30, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
An average volume of 3.01M can be a very valuable indicator of volatility for BAX stock. On a monthly basis, the volatility of the stock is set at 2.73%, whereas on a weekly basis, it is put at 2.55%, with a loss of -6.10% over the past seven days. Furthermore, long-term investors anticipate a median target price of $70.58, showing growth from the present price of $55.37, which can serve as yet another indication of whether BAX is worth investing in or should be passed over.
How Do You Analyze Baxter International Inc. Shares?
The USA based company Baxter International Inc. (BAX) is one of the biggest names in Medical Instruments & Supplies. When comparing Baxter International Inc. shares with other companies under Healthcare, the P/E value is an influential factor to note. This is because it represents an indication of the future growth of the company in terms of investors’ expectations. Ultimately, the value of the latter should demonstrate steady, rapid growth, which is an accurate measure of the company’s progress. In addition to the value of 27.74, there is a growth in quarterly earnings of -15.30%.
In addition to the fundamentals, you should also consider how many employees own shares in the company. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 0.10%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 89.10% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
Are institutional investors increasing their holdings in BAX shares?
The recent increase in stakes in BAX appears to be a result of several institutional investors and hedge funds increasing their positions. Wellington Management Co. LLP’s position in BAX has increased by 11.37% in the first quarter. The company now owns 61,887,205 shares of the stock, with a value of $3.56 billion, following the purchase of 6,317,261 additional shares during the last quarter. The Vanguard Group, Inc. made another increased to its shares in BAX during the first quarter, upping its stake by 2.00%. During the last quarter, the company picked up 760,013 additional shares for a total stake of worth $2.22 billion, bringing number of shares owned by the company to 38,704,699.
During the first quarter, BlackRock Fund Advisors added a 352,438 position in BAX. Morgan Stanley Investment Managem sold an additional -0.3 million shares in the last quarter, decreasing its holdings by -1.14%, now holding 26.31 million shares worth $1.51 billion. At the end of the first quarter, SSgA Funds Management, Inc. decreased its BAX holdings by -1.28% and now holds 21.4 million BAX shares valued at $1.23 billion with the lessened -0.28 million shares during the period. BAX shares are owned by institutional investors to the tune of 89.10% at present.